Click on a question to get the answer.
What is the history of Primatene® Tablets?
The first Primatene® Tablets were sold in 1954. The Primatene® brand has built a long-time heritage for over-the-counter relief of bronchial asthma.
What Primatene® Tablet products are available?
Primatene® Tablets containing two active ingredients: a bronchodilator - ephedrine HCL, and an expectorant - guaifenesin, are available in 24 tablet and 60 tablet packages.
Where can Primatene® Tablet products be purchased?
Primatene® Tablets are generally available in most major food, drug and mass merchandise retailers across the U.S., located behind the counter at the pharmacy.
What happened to Primatene® Dual Action Tablets?
A Food & Drug Administration ruling in July 1995 required manufacturers to discontinue marketing any over-the-counter (OTC) product containing Theophylline, an active ingredient in Primatene® Tablets and Primatene® Dual Action Tablets. Theophylline was reclassified and is now available only by prescription. Pfizer Consumer Healthcare stopped shipping Dual Action Tablets in January 1996. Primatene® Tablets, with a new formulation containing ephedrine and guaifenesin, began shipping in January 1996.
Are Primatene® Tablets gluten-free?
Yes. Primatene® Tablets are gluten-free. We obtain certification from our suppliers for all the raw materials that go into our products that a raw material was not made from wheat, rye, oats, triticale or barley and does not contain any ingredients that were derived from those grains.
Do Primatene® Tablets contain any of the following?
No. Primatene® Tablets do not contain any of the above.
What is a bronchodilator?
Bronchodilators are a group of drugs that help widen the airways in the lungs for the treatment of asthma and other conditions which constrict airflow in the lungs. Bronchodilators widen the bronchioles, to increase the flow of air and improve breathing.
What is an expectorant?
Expectorants are drugs that loosen mucus or phlegm in the lungs. Expectorants stimulate increased release of respiratory secretions. The increased release of secretions lowers the viscosity (thickness) of the bronchial secretions and permits easier removal from the respiratory tract.
An expectorant may be used with productive and non-productive coughs, to increase the amount of sputum expectorated.